symbol,statement_type,period_end,line_item,value
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Free Cash Flow,8393100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Repurchase Of Capital Stock,-3513400000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Repayment Of Debt,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Debt,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Issuance Of Capital Stock,100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure,-3179200000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,End Cash Position,1767900000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Beginning Cash Position,1294900000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Changes In Cash,473000000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Financing Cash Flow,-7334100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Other Financing Charges,-16100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Interest Paid Cff,-173100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Cash Dividends Paid,-3493700000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Common Stock Issuance,-3513300000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Common Stock Payments,-3513400000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Common Stock Issuance,100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Issuance Payments Of Debt,11000000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Long Term Debt Issuance,11000000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Payments,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Long Term Debt Issuance,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Investing Cash Flow,-3765200000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Other Investing Changes,440800000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Investment Purchase And Sale,-975700000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of Investment,26636400000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Investment,-27612100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Business Purchase And Sale,-62500000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Purchase Of Business,-62500000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net PPE Purchase And Sale,11400000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Sale Of PPE,11400000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Capital Expenditure Reported,-3179200000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Operating Cash Flow,11572300000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Taxes Refund Paid,-3229700000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Working Capital,1789300000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Liabilities,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Other Current Assets,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Payable,1071900000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Inventory,-745100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Change In Receivables,1057700000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Other Non Cash Items,-236800000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Stock Based Compensation,38800000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Depreciation And Amortization,1441100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Amortization Cash Flow,
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Depreciation,1441100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Investment Securities,-25200000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-103100000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Gain Loss On Sale Of PPE,6000000.0
AJANTPHARM.NS,cashflow,2025-03-31 00:00:00,Net Income From Continuing Operations,11891600000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Free Cash Flow,6326600000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Repurchase Of Capital Stock,-3882700000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Repayment Of Debt,
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Debt,
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Issuance Of Capital Stock,0.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure,-1524100000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,End Cash Position,1292300000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Beginning Cash Position,3298300000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Changes In Cash,-2006000000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Financing Cash Flow,-10510600000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Other Financing Charges,-9200000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Interest Paid Cff,-35300000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Cash Dividends Paid,-6421700000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Common Stock Issuance,-3882700000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Common Stock Payments,-3882700000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Common Stock Issuance,0.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Issuance Payments Of Debt,600000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Long Term Debt Issuance,600000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Payments,
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Long Term Debt Issuance,
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Investing Cash Flow,653900000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Other Investing Changes,270000000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Investment Purchase And Sale,1774200000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of Investment,22573900000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Investment,-20799700000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Business Purchase And Sale,0.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Purchase Of Business,0.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net PPE Purchase And Sale,133800000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Sale Of PPE,133800000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Capital Expenditure Reported,-1524100000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Operating Cash Flow,7850700000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Taxes Refund Paid,-3121300000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Working Capital,-997600000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Liabilities,733400000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Other Current Assets,-228200000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Payable,976100000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Inventory,-123000000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Change In Receivables,-2017000000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Other Non Cash Items,-201200000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Stock Based Compensation,54900000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Depreciation And Amortization,1354000000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Amortization Cash Flow,50100000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Depreciation,1354000000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Investment Securities,-248300000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-94200000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Gain Loss On Sale Of PPE,-34900000.0
AJANTPHARM.NS,cashflow,2024-03-31 00:00:00,Net Income From Continuing Operations,11139300000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Free Cash Flow,6176200000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Repurchase Of Capital Stock,-14400000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Repayment Of Debt,-4900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Issuance Of Debt,
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Issuance Of Capital Stock,0.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure,-1744900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,End Cash Position,3306700000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Beginning Cash Position,2063600000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Changes In Cash,1243100000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Financing Cash Flow,-1082000000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Other Financing Charges,-11100000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Interest Paid Cff,-23300000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Cash Dividends Paid,-896900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Common Stock Issuance,-14400000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Common Stock Payments,-14400000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Common Stock Issuance,0.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Issuance Payments Of Debt,-4900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Long Term Debt Issuance,-4900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Payments,-4900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Long Term Debt Issuance,
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Investing Cash Flow,-5596000000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Other Investing Changes,5200000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Investment Purchase And Sale,-3863600000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of Investment,12761500000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Investment,-16625100000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Business Purchase And Sale,
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Purchase Of Business,
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net PPE Purchase And Sale,7300000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Sale Of PPE,7300000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Capital Expenditure Reported,-1744900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Operating Cash Flow,7921100000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Taxes Refund Paid,-1512900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Working Capital,668500000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Liabilities,-323800000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Other Current Assets,404900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Payable,969100000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Inventory,-223700000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Change In Receivables,-215700000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Other Non Cash Items,55100000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Stock Based Compensation,2200000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Depreciation And Amortization,1308000000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Amortization Cash Flow,41000000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Depreciation,1267000000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Investment Securities,34800000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-140800000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Gain Loss On Sale Of PPE,61900000.0
AJANTPHARM.NS,cashflow,2023-03-31 00:00:00,Net Income From Continuing Operations,7452500000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Free Cash Flow,4128700000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Repurchase Of Capital Stock,-2855900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Repayment Of Debt,
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Issuance Of Debt,2300000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Issuance Of Capital Stock,
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure,-1488400000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,End Cash Position,2054100000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,-2391300000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Beginning Cash Position,1775100000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Changes In Cash,279000000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Financing Cash Flow,-4597100000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Other Financing Charges,-681900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Interest Paid Cff,-73500000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Cash Dividends Paid,-822100000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Common Stock Issuance,-2855900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Common Stock Payments,-2855900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Common Stock Issuance,
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Issuance Payments Of Debt,2300000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Long Term Debt Issuance,2300000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Payments,
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Long Term Debt Issuance,2300000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Investing Cash Flow,-741000000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Other Investing Changes,9000000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Investment Purchase And Sale,554600000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of Investment,10916500000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Investment,-10361900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Business Purchase And Sale,
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Purchase Of Business,
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net PPE Purchase And Sale,183800000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Sale Of PPE,183800000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Capital Expenditure Reported,-1488400000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Operating Cash Flow,5617100000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Taxes Refund Paid,-2391300000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Working Capital,-2003900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Liabilities,917500000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Other Current Assets,487100000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Payable,-480200000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Inventory,-256600000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Change In Receivables,-2680200000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Other Non Cash Items,98700000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Stock Based Compensation,3000000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Depreciation And Amortization,1253000000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Amortization Cash Flow,39400000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Depreciation,1213600000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Investment Securities,-303800000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,-211900000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Gain Loss On Sale Of PPE,38700000.0
AJANTPHARM.NS,cashflow,2022-03-31 00:00:00,Net Income From Continuing Operations,9094800000.0
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Free Cash Flow,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Repurchase Of Capital Stock,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Repayment Of Debt,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Issuance Of Debt,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Issuance Of Capital Stock,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,End Cash Position,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Other Cash Adjustment Outside Changein Cash,100000.0
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Beginning Cash Position,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Changes In Cash,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Financing Cash Flow,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Other Financing Charges,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Interest Paid Cff,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Cash Dividends Paid,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Common Stock Issuance,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Common Stock Payments,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Common Stock Issuance,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Issuance Payments Of Debt,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Long Term Debt Issuance,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Payments,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Long Term Debt Issuance,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Investing Cash Flow,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Other Investing Changes,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Investment Purchase And Sale,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of Investment,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Investment,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Business Purchase And Sale,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Purchase Of Business,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net PPE Purchase And Sale,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Sale Of PPE,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Capital Expenditure Reported,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Operating Cash Flow,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Taxes Refund Paid,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Working Capital,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Liabilities,450600000.0
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Other Current Assets,-291300000.0
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Payable,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Inventory,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Change In Receivables,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Other Non Cash Items,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Stock Based Compensation,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Depreciation And Amortization,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Amortization Cash Flow,46900000.0
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Depreciation,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Investment Securities,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Foreign Currency Exchange Gain Loss,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Gain Loss On Sale Of PPE,
AJANTPHARM.NS,cashflow,2021-03-31 00:00:00,Net Income From Continuing Operations,
